Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA.
Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA.
Int J Pharm. 2019 Jan 30;555:109-123. doi: 10.1016/j.ijpharm.2018.11.044. Epub 2018 Nov 16.
The future of pharmaceutical manufacturing may be significantly transformed by 3-dimensional (3D) printing. As an emerging technology, the indicators of quality for materials and processes used in 3D printing have not been fully established. The objective of this study was to identify the critical material attributes of semisolid paste formulations filled into cartridges for 3D printing of personalized medicine. Nineteen semisolid formulations were prepared per a fractional factorial design with three replicates of the center point. The variables investigated included percent loading of API and various soluble and insoluble excipients. Pastes were characterized for viscoelastic characteristics during the 3D printing process including creep recovery, cross-modulus and extrudability models. Packing efficiency of pastes into 3D printing cartridges was also evaluated by X-ray tomography. Changes in composition of 3D printing pastes resulted in significant variations in their viscoelastic parameters, namely their elastic deformation, flow and relaxation behaviors. The percent of soluble excipients incorporated was the most significant factor affecting the creep behavior of pastes. Cross-over stresses were assessed to indicate the minimum pressure needed for the pastes to initiate flow. Increasing solid and swellable contents of the pastes from 7% to 63% w/w increased significantly (p < 0.05) the cross-over stress from 0.93 × 10 Pa to 9.47 × 10 Pa. Increasing soluble ingredients of paste from 30% to 80% w/w was found to increase flow of the paste from 0.41 × 10 to 3.85 × 10 %/s. X-ray tomography images revealed inclusion of air bubbles during packing of pastes into cartridges. These bubbles may affect the relaxation behavior of the pastes; hence bubbles should be eliminated. This study unveiled the critical material attributes that could be controlled for consistent 3D printing by microextrusion.
3 维(3D)打印可能会显著改变制药生产的未来。作为一项新兴技术,3D 打印所使用的材料和工艺的质量指标尚未完全确立。本研究的目的是确定用于 3D 打印个体化药物的装料筒中半固态膏剂制剂的关键材料属性。采用三因素部分析因设计,每个因素 3 个水平,共制备了 19 种半固态制剂,中心点有 3 个重复。考察的变量包括 API 的负载百分比和各种可溶性和不溶性赋形剂。在 3D 打印过程中,对膏剂的粘弹性特性进行了研究,包括蠕变恢复、交叉模量和挤出性模型。还通过 X 射线断层扫描评估了膏剂装入 3D 打印装料筒的填充效率。3D 打印膏剂的组成变化导致其粘弹性参数发生显著变化,即其弹性变形、流动和松弛行为。所加入的可溶性赋形剂的百分比是影响膏剂蠕变行为的最主要因素。交叉应力用于评估膏剂开始流动所需的最小压力。将膏剂的固含量和溶胀含量从 7%增加到 63%(w/w),显著增加(p<0.05)交叉应力从 0.93×10Pa 增加到 9.47×10Pa。将膏剂中可溶性成分的含量从 30%增加到 80%(w/w),发现膏剂的流动度从 0.41×10%/s 增加到 3.85×10%/s。X 射线断层扫描图像显示,在将膏剂装入装料筒的过程中会夹带气泡。这些气泡可能会影响膏剂的松弛行为,因此应消除气泡。本研究揭示了通过微挤出可控制的关键材料属性,从而实现一致的 3D 打印。